A Case Control Study on Serum Levels of Potential Biomarkers in Male Breast Cancer Patients
- PMID: 34062830
- PMCID: PMC8125742
- DOI: 10.3390/ijerph18094852
A Case Control Study on Serum Levels of Potential Biomarkers in Male Breast Cancer Patients
Abstract
The global incidence of breast cancer among men is steadily growing. Despite this, compared to female breast cancer patients, there are very few studies on biomarkers in male breast cancer patients. A cross-sectional case control study was carried out to determine the serum levels of melatonin, ghrelin, dopamine, serotonin, epinephrine, and GABA in male breast cancer. All the recruited patients were obese, old, and had recently been diagnosed with the disease. They had not received any treatment for the cancer until the time of the study. Melatonin and epinephrine serum levels were significantly higher in breast cancer patients compared to their age-matched controls, whereas ghrelin, dopamine, GABA, and serotonin serum levels were lower in patients compared to the control group. The serum levels of most of the studied biomarkers in male breast cancer patients were similar to those observed in female breast cancer patients, except for serum melatonin levels.
Keywords: GABA; dopamine; epinephrine; ghrelin; melatonin; serotonin.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.PLoS One. 2016 Aug 11;11(8):e0160892. doi: 10.1371/journal.pone.0160892. eCollection 2016. PLoS One. 2016. PMID: 27513937 Free PMC article.
-
Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.J Pediatr. 2014 Jul;165(1):184-189.e1. doi: 10.1016/j.jpeds.2014.03.061. Epub 2014 May 22. J Pediatr. 2014. PMID: 24857519 Free PMC article. Clinical Trial.
-
Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):413-419. doi: 10.1158/1055-9965.EPI-16-0630. Epub 2016 Nov 9. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28151704 Free PMC article.
-
The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature.J Pineal Res. 1999 Mar;26(2):65-100. doi: 10.1111/j.1600-079x.1999.tb00568.x. J Pineal Res. 1999. PMID: 10100735 Review.
-
Repercussions of melatonin on the risk of breast cancer: a systematic review and meta-analysis.Rev Assoc Med Bras (1992). 2019 Jun 3;65(5):699-705. doi: 10.1590/1806-9282.65.5.699. Rev Assoc Med Bras (1992). 2019. PMID: 31166448
Cited by
-
Machine learning-assisted quantitative metabolomics of West African patients with advanced breast cancer.Sci Rep. 2025 Aug 12;15(1):29603. doi: 10.1038/s41598-025-13475-5. Sci Rep. 2025. PMID: 40796634 Free PMC article.
-
Dopamine receptors gene overexpression in the microenvironment of invasive gastric cancer and its potential implications.Mol Biol Rep. 2023 Aug;50(8):6529-6542. doi: 10.1007/s11033-023-08541-y. Epub 2023 Jun 18. Mol Biol Rep. 2023. PMID: 37330941
-
Establishment of Prognostic Nomogram for Male Breast Cancer Patients: A Surveillance, Epidemiology and End Results Database Analysis.Cancer Control. 2024 Jan-Dec;31:10732748241270628. doi: 10.1177/10732748241270628. Cancer Control. 2024. PMID: 39116271 Free PMC article.
-
GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer.Front Oncol. 2023 Jul 4;13:1142017. doi: 10.3389/fonc.2023.1142017. eCollection 2023. Front Oncol. 2023. PMID: 37469414 Free PMC article.
References
-
- Cronin P.A., Romanoff A., Zabor E.C., Stempel M., Eaton A., Smyth L.M., Alice Y.H., Monica M., Mahmoud E.T., Gemignani M.L., et al. Annals of Surgical Oncology. Volume 25. Springer; New York, NY, USA: 2018. Influence of age on the clinical outcome of breast cancer for men and the development of second primary cancers; pp. 3858–3866. - PMC - PubMed
-
- Abdelwahab Yousef A.J. Seminars in Oncology. WB Saunders; Philadelphia, PA, USA: 2017. Male breast cancer: Epidemiology and risk factors. - PubMed
-
- Lydiard R.B. The role of GABA in anxiety disorders. J. Clin. Psychiatry. 2003;64(Suppl. 3):21–27. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical